ATE192647T1 - Medikamente auf der basis von docosahexaensäure, als plättchenaggregationshemmer und gegen cerebralen mangel an fettsäuren, und verfahren zur herstellung. - Google Patents

Medikamente auf der basis von docosahexaensäure, als plättchenaggregationshemmer und gegen cerebralen mangel an fettsäuren, und verfahren zur herstellung.

Info

Publication number
ATE192647T1
ATE192647T1 AT94900873T AT94900873T ATE192647T1 AT E192647 T1 ATE192647 T1 AT E192647T1 AT 94900873 T AT94900873 T AT 94900873T AT 94900873 T AT94900873 T AT 94900873T AT E192647 T1 ATE192647 T1 AT E192647T1
Authority
AT
Austria
Prior art keywords
pct
dha
platele
production
fatty acids
Prior art date
Application number
AT94900873T
Other languages
English (en)
Inventor
Yves Bayon
Martine Croset
Michel Lagarde
Jean Lecerf
Frank Thies
Jean-Louis Tayot
Veronique Chirouze
Original Assignee
Inst Nat Sante Rech Med
Imedex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Imedex filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE192647T1 publication Critical patent/ATE192647T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT94900873T 1992-11-24 1993-11-24 Medikamente auf der basis von docosahexaensäure, als plättchenaggregationshemmer und gegen cerebralen mangel an fettsäuren, und verfahren zur herstellung. ATE192647T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9214078A FR2698269B1 (fr) 1992-11-24 1992-11-24 Nouveaux médicaments à base d'acides gras insaturés, utilisables notamment comme antiagrégants plaquettaires et/ou comme transporteurs privilégiés vers le cerveau.
PCT/FR1993/001158 WO1994012170A2 (fr) 1992-11-24 1993-11-24 Medicaments a base d'acides gras polyinsatures, notamment d'acides docosahexaenoique comme antiagregants plaquettaires et contre des carences cerebrales en acides gras essentiels.

Publications (1)

Publication Number Publication Date
ATE192647T1 true ATE192647T1 (de) 2000-05-15

Family

ID=9435824

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94900873T ATE192647T1 (de) 1992-11-24 1993-11-24 Medikamente auf der basis von docosahexaensäure, als plättchenaggregationshemmer und gegen cerebralen mangel an fettsäuren, und verfahren zur herstellung.

Country Status (10)

Country Link
US (1) US5654290A (de)
EP (1) EP0623019B1 (de)
JP (1) JPH07503488A (de)
AT (1) ATE192647T1 (de)
CA (1) CA2128706C (de)
DE (1) DE69328618T2 (de)
DK (1) DK0623019T3 (de)
ES (1) ES2149253T3 (de)
FR (1) FR2698269B1 (de)
WO (1) WO1994012170A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107499A (en) * 1988-02-26 2000-08-22 Neuromedica, Inc. Dopamine analog amide
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6197764B1 (en) 1997-11-26 2001-03-06 Protarga, Inc. Clozapine compositions and uses thereof
US5955459A (en) * 1997-11-26 1999-09-21 Neuromedica, Inc. Fatty acid-antipsychotic compositions and uses thereof
US5977174A (en) * 1997-11-26 1999-11-02 Neuromedica, Inc. Cholinergic compositions and uses thereof
US6153653A (en) * 1997-11-26 2000-11-28 Protarga, Inc. Choline compositions and uses thereof
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
US7235583B1 (en) * 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
ES2387562T3 (es) 2001-03-23 2012-09-26 Luitpold Pharmaceuticals, Inc. Conjugados alcohol graso-medicamento
EP1427407A4 (de) 2001-03-23 2005-05-11 Luitpold Pharm Inc Fettamin-arzneimittel-konjugate
IL142952A (en) * 2001-05-03 2005-12-18 Enzmotec Ltd Process for enzyme-catalyzed production of 1,2 diacylated phospholipids
FR2857265A1 (fr) * 2003-07-08 2005-01-14 Clinigenetics Utilisation de lyso-pcdha pour le traitement des maladies cardiovasculaires
WO2004091603A1 (fr) * 2003-04-07 2004-10-28 Clinigenetics Utilisation d’un ester de dha pour le traitement des malades cardiovasculaires
EP1466597A1 (de) * 2003-04-07 2004-10-13 Clinigenetics Verwendung von dha-Esteren in der Behandlung kardiovasculärer Krankheiten
CA2549429A1 (en) * 2003-12-22 2005-07-07 Wakunaga Pharmaceutical Co., Ltd. Fat composition
JP5352961B2 (ja) * 2006-03-28 2013-11-27 Ｊｎｃ株式会社 生活習慣病予防・治療剤
FR2979825B1 (fr) 2011-09-13 2013-11-29 Inst Nat Sciences Appliq Phosphatidylcholines specifiques en tant que modulateurs de l'activite du facteur d'activation plaquettaire
AU2014203179C1 (en) * 2013-06-14 2017-05-04 Aker Biomarine Antarctic As Lipid extraction processes
US9549937B2 (en) 2013-12-05 2017-01-24 Burvia, LLC. Composition containing phospholipid-DHA and folate
US9610302B2 (en) 2013-12-05 2017-04-04 Buriva, LLC. Composition containing phospholipid-DHA and B vitamins
US9233114B2 (en) 2013-12-05 2016-01-12 Buriva, LLC Dietary supplement containing phospholipid-DHA derived from eggs
US9216199B2 (en) 2013-12-05 2015-12-22 Buriva, LLC Nutritional supplement containing phospholipid-DHA derived from eggs
SG11202005905TA (en) 2017-12-21 2020-07-29 Aker Biomarine Antarctic As Lysophosphatidylcholine compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098065A (en) * 1981-04-14 1982-11-17 Nippon Suisan Kaisha Ltd Antithrombotic compositions containing docosahexaenoic acid
IT1223290B (it) * 1987-07-27 1990-09-19 Indena Spa Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
JPS6450890A (en) * 1987-08-20 1989-02-27 Nippon Oils & Fats Co Ltd Production of docosahexaenoic acid-containing phosphatidyl choline
JP2537645B2 (ja) * 1987-11-13 1996-09-25 雪印乳業株式会社 薬剤的活性を有する栄養組成物
JPH01203330A (ja) * 1988-02-05 1989-08-16 Rikagaku Kenkyusho 制癌剤
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
GB2218904A (en) * 1988-05-27 1989-11-29 Renafield Limited Pharmaceutical composition based on high-concentration esters of docosahexaenoic acid
IT1230141B (it) * 1989-05-03 1991-10-14 Fidia Spa Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale.
JPH03178931A (ja) * 1989-09-08 1991-08-02 Nippon Oil & Fats Co Ltd 睡眠増加剤
JPH0748992B2 (ja) * 1990-04-16 1995-05-31 日本油脂株式会社 血栓防止用粉末組成物
JP3092180B2 (ja) * 1991-02-27 2000-09-25 日本油脂株式会社 低密度リポ蛋白受容体活性化剤

Also Published As

Publication number Publication date
CA2128706C (en) 2007-07-10
WO1994012170A3 (fr) 1994-07-21
JPH07503488A (ja) 1995-04-13
DE69328618T2 (de) 2001-02-01
CA2128706A1 (en) 1994-06-09
DE69328618D1 (de) 2000-06-15
DK0623019T3 (da) 2000-10-02
FR2698269B1 (fr) 1995-01-06
FR2698269A1 (fr) 1994-05-27
WO1994012170A2 (fr) 1994-06-09
EP0623019B1 (de) 2000-05-10
EP0623019A1 (de) 1994-11-09
ES2149253T3 (es) 2000-11-01
US5654290A (en) 1997-08-05

Similar Documents

Publication Publication Date Title
ATE192647T1 (de) Medikamente auf der basis von docosahexaensäure, als plättchenaggregationshemmer und gegen cerebralen mangel an fettsäuren, und verfahren zur herstellung.
PT774962E (pt) Utilizacao de dha como uma composicao farmaceutica
EP1961312A3 (de) Mischung von mikrobiellen Ölen und deren Verwendungen
AU2671292A (en) Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases
DE59808773D1 (de) Verwendung synthetischer Triglyceride auf Basis konjugierter Linolsäure zur Herstellung von Mitteln zur Behandlung von katabolischen Zuständen
ATE75502T1 (de) Verfahren zur herstellung von polyungesaettigten fettsaeuren.
ID21473A (id) Sediaan farmasi yang mengandung asam eikosapentanoat dan asam stearidonat
NO980282D0 (no) Beroligelses-feromoner for stress-angst- og aggresivitet hos griser
DE69601472T2 (de) Zusätze und brennölzusammensetzungen
ATE408701T1 (de) Verfahren zur herstellung von hochungesättigten fettsäuren und hochungesättigte fettsäuren enthaltendes lipid
DE60034919D1 (de) Kosmetische Zubereitung Ester hydroxylierter Fettsäuren enthaltend
DE69223722D1 (de) Verfahren zur Herstellung von 8,11-Eicasodiensäure
DE69633009D1 (de) Nicotinsäureester und diese enthaltende pharmazeutischen zusammensetzungen
ATE141588T1 (de) Polymerisationsinhibitoren für acrylsäure und ester
AU2001281415A1 (en) Enhancement of the action of central and peripheral nervous system agents
ATE60508T1 (de) Eisen enthaltende zusammensetzung und verfahren zur behandlung von krebs.
KR0140401B1 (en) Anti-bloom triglyceride compositions
ATE43348T1 (de) Acylierte cytidin-diphosphat-choline, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
DE69005317D1 (de) Verfahren und Zwischenprodukte zur Herstellung von Isopropylestern von 3S-amino-2R-hydroxyalkansäuren.
DE2806804A1 (de) Verfahren zur inhibition von lipasen
ES2155026A1 (es) Formulacion y procedimiento de obtencion de una salsa tipo garum romano.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee